FDA Import Refusal 1FX-1355997-5/20001/1 — Lilly Corporate Center-Lcc
The FDA refused shipment 1FX-1355997-5/20001/1 from Lilly Corporate Center-Lcc (United States) on Apr 14, 2026. The refused product falls under Drugs and Biologics — SOMATROPIN. Cited charge: 75
Refusal Details
- Date
- Apr 14, 2026
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 58HAY05 SOMATROPIN
- Charges
- 75